净利润增长
Search documents
通达股份(002560.SZ):预计2025年净利润同比增长438.19%-614.71%
Ge Long Hui A P P· 2026-01-23 15:34
格隆汇1月23日丨通达股份(维权)(002560.SZ)公布,预计2025年归属于上市公司股东的净利润13,720 万元-18,220万元,比上年同期增长438.19%-614.71%,扣除非经常性损益后的净利润12,906万元-17,406 万元,比上年同期增长647.18%-907.70%。 1、报告期内,公司聚焦优势业务,优化客户结构,落实高质量发展目标,实现营业收入持续快速增 长,同时产品毛利率趋于稳定。2、报告期内,子公司成都航飞航空机械设备制造有限公司订单饱满, 且订单交付量显著提升,实现了营业收入和利润率的双重回升。 ...
威唐工业(300707.SZ):预计2025年净利润同比增长58.17%~101.31%
Xin Lang Cai Jing· 2026-01-23 14:47
Core Viewpoint - Weitang Industrial (300707.SZ) expects a net profit attributable to shareholders of 33 million to 42 million yuan for 2025, representing a year-on-year growth of 58.17% to 101.31% [1] Group 1: Financial Performance - The net profit after deducting non-recurring gains and losses is projected to be between 33 million and 42 million yuan, indicating a growth of 93.47% to 146.24% compared to the previous year [1] - The company has improved its profitability by enhancing inventory and accounts receivable management [1] Group 2: Market Expansion - During the reporting period, the company continued to deepen its expansion into the North American and European markets, leading to an increase in revenue from automotive stamping mold business compared to the previous year [1] Group 3: Financial Management - The company experienced a gain from foreign exchange due to fluctuations in the RMB exchange rate, resulting in a decrease in financial expenses compared to the same period last year [1] - The expected amount of non-recurring gains and losses attributable to shareholders is approximately -20,000 yuan [1]
融捷健康(300247.SZ):预计2025年净利润同比增长60.07%~87.82%
Ge Long Hui A P P· 2026-01-23 14:20
Core Viewpoint - Rongjie Health (300247.SZ) expects a net profit attributable to shareholders of 75 million to 88 million yuan for 2025, representing a year-on-year growth of 60.07% to 87.82% [1] Group 1: Financial Performance - The net profit excluding non-recurring gains and losses is projected to be between 70 million and 83 million yuan, indicating a year-on-year increase of 77.78% to 110.79% [1] - The company achieved continuous sales growth through capacity expansion, supply chain optimization, operational efficiency improvements, and innovative processes [1] - The overall gross margin has improved compared to the same period last year [1] Group 2: Impact of Market Conditions - The fair value of investment properties experienced impairment due to market influences, resulting in a higher growth rate of net profit excluding non-recurring items compared to the net profit attributable to shareholders [1]
台基股份(300046.SZ):预计2025年净利润同比增长79.1%~132.47%
Ge Long Hui A P P· 2026-01-23 12:35
Core Viewpoint - Taiji Co., Ltd. (300046.SZ) expects a net profit attributable to shareholders of 45.3 million to 58.8 million yuan for 2025, representing a year-on-year growth of 79.10% to 132.47% [1] Financial Performance - The net profit after deducting non-recurring gains and losses is projected to be between 29 million and 37 million yuan, indicating a decline of 22.26% to 39.07% compared to the same period last year [1] - The company anticipates that non-recurring gains and losses will impact net profit by approximately 19 million yuan for the 2025 fiscal year [1] Investment Income - The increase in income from financial products is noted as a contributing factor to the expected profit growth [1]
安硕信息:预计2025年净利润同比增长52.44%—98.83%
Zheng Quan Shi Bao Wang· 2026-01-23 10:32
Core Viewpoint - The company Anshuo Information (300380) expects a significant increase in net profit for 2025, projecting a range of 23 million to 30 million yuan, which represents a year-on-year growth of 52.44% to 98.83% [1] Financial Projections - The anticipated net profit for 2025 is between 23 million and 30 million yuan [1] - The expected year-on-year growth rate for net profit is between 52.44% and 98.83% [1] - Non-recurring gains and losses are projected to impact net profit by approximately 8.8 million yuan, primarily from government subsidies [1]
天津发展(00882):力生制药预计2025年度净利润4亿元-4.4亿元 同比增长116.77%-138.44%
智通财经网· 2026-01-23 10:13
报告期内,公司持续加大市场拓展力度,产品销售有所提升;加之天士力生物医药产业集团有限公司分 红因素影响,归属于上市公司股东的净利润同比增幅较大。 智通财经APP讯,天津发展(00882)发布公告,预计2025年度,公司间接非全资附属公司天津力生制药股 份有限公司(力生制药)实现归属于上市公司股东的净利润盈利4亿元-4.4亿元,上年同期盈利1.85亿元, 比上年同期增长116.77%-138.44%;期内扣除非经常性损益后的净利润盈利1.6亿元-1.9亿元,上年同期盈 利1.03亿元,比上年同期增长55.34%-84.47%;基本每股收益1.50元/股-1.80元/股。 ...
金麒麟:预计2025年净利润同比增加58.36%
Xin Lang Cai Jing· 2026-01-23 09:13
金麒麟公告,预计2025年年度实现归属于上市公司股东的净利润1.46亿元,与上年同期相比,将增加 5378.88万元左右,同比增加58.36%左右。预计2025年年度实现归属于上市公司股东的扣除非经常性损 益后的净利润1.36亿元,与上年同期相比,将增加4258.29万元,同比增加45.53%左右。报告期内,公 司模具周期管理机制得到有效改善,订单交付提升,产品发运环节运营费用降低。本期收到投资基金分 红。市场汇率波动影响。 ...
中新集团(601512.SH):预计2025年度净利润同比增加59.18%
Xin Lang Cai Jing· 2026-01-23 08:35
Core Viewpoint - China New Group (601512.SH) is expected to achieve a net profit attributable to shareholders of 1.014 billion yuan in 2025, representing an increase of 377 million yuan or 59.18% compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, of 944 million yuan for 2025, which is an increase of 379 million yuan or 67.08% year-on-year [1]
祥源新材:预计2025年净利润同比增长67.16%~102.56%
Xin Lang Cai Jing· 2026-01-23 08:29
Core Viewpoint - The company expects a net profit of 42.75 million to 51.81 million yuan for the year 2025, representing a year-on-year growth of 67.16% to 102.56% [1] Group 1: Financial Performance - The projected net profit for 2025 is between 42.75 million and 51.81 million yuan [1] - This represents a significant year-on-year increase of 67.16% to 102.56% [1] Group 2: Business Development - The company is intensifying its efforts in expanding international markets, leading to gradual growth in overseas business [1] - The overall revenue has seen a notable increase due to rising demand in downstream application sectors and the gradual realization of orders in related new application fields [1]
西菱动力:预计去年归母净利润同比增约77.8%-117%
Xin Jing Bao· 2026-01-23 08:25
Group 1 - The core viewpoint of the article is that Xiling Power (300733) expects a significant increase in net profit for the fiscal year 2025, projecting between 90 million to 110 million yuan, which represents a year-on-year growth of 77.82% to 117.33% [1] - The company's automotive parts products, including camshaft assemblies, connecting rod assemblies, and crankshaft dampers, are experiencing a gradual increase in sales volume from new customers [1] - The utilization rate of production capacity is improving, and sales of turbocharger products are maintaining stable growth [1] Group 2 - The military and aviation parts industry is seeing an increase in demand, contributing to the company's rapid business growth [1]